AI in Disease Outbreak Prediction Market Report 2026

The artificial intelligence (AI) in disease outbreak prediction market size has grown exponentially in recent years. It will grow from $2.44 billion in 2025 to $3.09 billion in 2026 at a compound annual growth rate (CAGR) of 26.7%. The growth in the historic period can be attributed to increasing frequency of infectious disease outbreaks, expansion of public health surveillance programs, growth of health data digitization, early adoption of AI analytics in epidemiology, increased collaboration between health agencies.

The artificial intelligence (AI) in disease outbreak prediction market size is expected to see exponential growth in the next few years. It will grow to $8.02 billion in 2030 at a compound annual growth rate (CAGR) of 27%. The growth in the forecast period can be attributed to expansion of predictive public health infrastructure, rising investments in AI-driven disease preparedness, growing use of real-time health monitoring data, increasing integration of climate and mobility analytics, expansion of global health intelligence networks. Major trends in the forecast period include increasing use of real-time epidemiological modeling, rising integration of mobility and environmental data sources, growing deployment of AI-based surveillance dashboards, expansion of predictive risk assessment platforms, enhanced focus on early warning systems.

The rising investments in digital health infrastructure are expected to fuel the growth of the artificial intelligence in disease outbreak prediction market going forward. Digital health infrastructure refers to integrated digital systems, platforms, data networks, and technologies that support the secure collection, exchange, analysis, and utilization of health information to enable healthcare delivery, public health surveillance, and informed decision-making. The growth in investments in digital health infrastructure is driven by the need for more efficient, connected, and data-driven healthcare systems that enhance care delivery, accessibility, and operational efficiency. Artificial intelligence in disease outbreak prediction relies on digital health infrastructure by using large-scale, real-time health data for early identification of disease trends and timely public health responses, making advanced digital systems a vital foundation for these AI applications. For instance, in May 2023, according to the Australian Department of Health and Aged Care, an Australia-based government department, an investment of around $6.1 billion was announced to strengthen Medicare, including $2.2 billion for new and amended PBS listings, $259.5 million for critical health infrastructure, and a $951.2 million digital health package. Therefore, increasing investments in digital health infrastructure are driving the growth of the artificial intelligence in disease outbreak prediction market.

Leading companies operating in the artificial intelligence in disease outbreak prediction market are focusing on developing advanced solutions, such as artificial intelligence-driven global disease surveillance platforms, to improve early outbreak detection, accelerate response times, and strengthen public health preparedness. Artificial intelligence-driven global disease surveillance platforms refer to systems that use artificial intelligence, machine learning, and natural language processing to analyze large volumes of global data sources, including news reports, public health records, airline travel data, and environmental indicators, to identify potential disease outbreaks earlier than conventional surveillance methods. For example, in August 2024, BlueDot, a Canada-based digital health and artificial intelligence company, unveiled its next-generation global infectious disease surveillance solution designed to significantly reduce manual detection time. The platform leverages advanced AI models to continuously scan and interpret global data in near real time, lowering manual detection efforts by nearly 90%. This enhanced capability enables health authorities and organizations to identify emerging infectious threats more rapidly, evaluate risks more accurately, and implement timely containment measures.

In June 2023, Health Matrix, a Saudi Arabia-based provider of digital health transformation solutions and public health digital offerings delivered through technology platforms and services, partnered with BlueDot Inc. to expand its public health digital portfolio by integrating advanced artificial intelligence-driven infectious disease intelligence. Through this collaboration, Health Matrix seeks to strengthen its healthcare digital capabilities and equip regional healthcare stakeholders with predictive outbreak intelligence and global surveillance technologies. BlueDot Inc. is a Canada-based infectious disease intelligence company that develops machine learning- and human-intelligence-powered global early warning surveillance systems to track infectious diseases and enable data-driven responses to health threats worldwide.

Major companies operating in the artificial intelligence (AI) in disease outbreak prediction market are Amazon Web Services Inc., Oracle Corporation, SAP SE, Siemens Healthineers AG, SAS Institute Inc., Clarivate Plc, Tempus AI Inc., Seegene Inc., Ginkgo Bioworks Inc., Dataminr Inc., Komodo Health Inc., H2O.ai, Evidation Health Inc., Qventus Inc., Airfinity Ltd., SparkBeyond Inc., Blue Dot Inc., GIDEON Informatics Inc., Hyfe Inc., EPIWATCH Pty Ltd., EpiDetect AI Inc.

Tariffs are impacting the artificial intelligence in disease outbreak prediction market by increasing costs of imported sensors, health monitoring devices, cloud infrastructure hardware, and advanced computing equipment used for large-scale analytics. Public health agencies and research institutions in North America and Europe are most affected due to reliance on imported digital health infrastructure, while Asia-Pacific faces higher costs for exporting analytics platforms bundled with hardware. These tariffs are raising system deployment costs and extending procurement timelines. However, they are also encouraging local data infrastructure development, regional manufacturing of health sensors, and greater adoption of cloud-based analytics platforms.

The artificial intelligence (AI) in disease outbreak prediction market research report is one of a series of new reports that provides artificial intelligence (AI) in disease outbreak prediction market statistics, including artificial intelligence (AI) in disease outbreak prediction industry global market size, regional shares, competitors with a artificial intelligence (AI) in disease outbreak prediction market share, detailed artificial intelligence (AI) in disease outbreak prediction market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in disease outbreak prediction industry. This artificial intelligence (AI) in disease outbreak prediction market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial intelligence (AI) in disease outbreak prediction involves applying AI models to analyze extensive health, environmental, mobility, and demographic datasets to detect patterns associated with disease emergence and transmission. It aims to forecast potential outbreaks more rapidly and accurately than traditional surveillance approaches by learning continuously from real-time and historical information. The objective is to enhance preparedness, risk evaluation, and response planning through data-driven insights.

The primary components of artificial intelligence (AI) in disease outbreak prediction include software, hardware, and services. Software refers to applications and platforms that analyze data, model disease spread, and provide predictive insights for outbreak management. These solutions are deployed in modes such as on-premises and cloud. They are applied across areas including healthcare providers, government agencies, research institutes, pharmaceutical companies, and other applications, and are used by end users including hospitals and clinics, public health organizations, academic and research centers, and other end users.

The artificial intelligence (AI) in disease outbreak prediction market consists of revenues earned by entities by providing services such as disease surveillance services, outbreak modeling services, predictive analytics services, public health consulting, data integration services, epidemiological risk assessment, health monitoring services, and training and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in disease outbreak prediction market also includes sales of software platforms, predictive modeling tools, outbreak detection systems, data analytics dashboards, geographic information system devices, health monitoring sensors, cloud computing infrastructure, and epidemic simulation kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.